|
Cai, Zheng; Fu, Ting; Nagai, Yasuhiro et al. (2013) scFv-based ""Grababody"" as a general strategy to improve recruitment of immune effector cells to antibody-targeted tumors. Cancer Res 73:2619-27
|
|
Du, Taofeng; Nagai, Yasuhiro; Xiao, Yan et al. (2013) Lysosome-dependent p300/FOXP3 degradation and limits Treg cell functions and enhances targeted therapy against cancers. Exp Mol Pathol 95:38-45
|
|
Huang, J-M; Nagatomo, I; Suzuki, E et al. (2013) YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14. Oncogene 32:2220-9
|
|
Runkle, E Aaron; Zhang, Hongtao; Cai, Zheng et al. (2012) Reversion of the ErbB malignant phenotype and the DNA damage response. Exp Mol Pathol 93:324-33
|
|
Lam, Lian; McAndrew, Nicholas; Yee, Marla et al. (2012) Challenges in the clinical utility of the serum test for HER2 ECD. Biochim Biophys Acta 1826:199-208
|
|
Berezov, A; Cai, Z; Freudenberg, J A et al. (2012) Disabling the mitotic spindle and tumor growth by targeting a cavity-induced allosteric site of survivin. Oncogene 31:1938-48
|
|
Song, Xiaomin; Li, Bin; Xiao, Yan et al. (2012) Structural and biological features of FOXP3 dimerization relevant to regulatory T cell function. Cell Rep 1:665-75
|
|
Fu, Weihua; Madan, Elena; Yee, Marla et al. (2012) Progress of molecular targeted therapies for prostate cancers. Biochim Biophys Acta 1825:140-52
|
|
Ponde, Datta E; Su, ZiFen; Berezov, Alan et al. (2011) Development of anti-EGF receptor peptidomimetics (AERP) as tumor imaging agent. Bioorg Med Chem Lett 21:2550-3
|
|
Cai, Zheng; Zhang, Hongtao; Liu, Jing et al. (2010) Targeting erbB receptors. Semin Cell Dev Biol 21:961-6
|
Showing the most recent 10 out of 12 publications
